Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
228 USD | -0.05% | -3.43% | -3.89% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.89% | 11.75B | |
+22.44% | 44.96B | |
+0.79% | 42.65B | |
+46.00% | 41.85B | |
-4.27% | 29.04B | |
+10.87% | 26.08B | |
-20.74% | 19.03B | |
+5.24% | 12.75B | |
+27.54% | 12.06B | |
+20.99% | 11.72B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Guggenheim Adjusts Price Target on Charles River Laboratories International to $225 From $255, Maintains Buy Rating